Advocate Group’s Colgate-Palmolive CL Stock Holding History

Advocate Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$650K	Sell	7,622 -700	-8%	-$63.4K	0.1%	91
2026 Q2	$763K	Sell	8,322 -59	-0.7%	-$5.16K	0.11%	89
2026 Q1	$714K	Sell	8,381 -50	-0.6%	-$4.46K	0.11%	90
2025 Q4	$666K	Hold	8,431	–	–	0.11%	89
2025 Q3	$674K	Hold	8,431	–	–	0.11%	87
2025 Q2	$766K	Sell	8,431 -488	-5%	-$44.6K	0.14%	85
2025 Q1	$836K	Sell	8,919 -40	-0.4%	-$3.58K	0.15%	81
2024 Q4	$814K	Hold	8,959	–	–	0.15%	81
2024 Q3	$930K	Hold	8,959	–	–	0.17%	82
2024 Q2	$869K	Hold	8,959	–	–	0.18%	82
2024 Q1	$807K	Sell	8,959 -758	-8%	-$64.2K	0.16%	86
2023 Q4	$775K	Sell	9,717 -863	-8%	-$64.9K	0.17%	86
2023 Q3	$752K	Sell	10,580 -1,566	-13%	-$117K	0.17%	84
2023 Q2	$936K	Sell	12,146 -374	-3%	-$29K	0.21%	79
2023 Q1	$941K	Sell	12,520 -6,341	-34%	-$472K	0.21%	81
2022 Q4	$1.49M	Sell	18,861 -2,036	-10%	-$153K	0.32%	67
2022 Q3	$1.47M	Sell	20,897 -3,259	-13%	-$256K	0.36%	63
2022 Q2	$1.94M	Buy	+24,156	New	+$1.89M	0.45%	61

Other funds holding CL

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return

Advocate Group's CL Position: Q3 2026 in Review

Advocate Group reduced its Colgate-Palmolive (CL) stake by 8.4% in Q3 2026, selling an estimated $63.4K and leaving 7,622 shares worth $650K. The position accounts for 0.1% of the portfolio, ranked #91.

Advocate Group first reported a position in CL in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.94M in Q2 2022. 861 funds tracked by Wall St. Rank hold CL as of Q3 2026.

Advocate Group held 7,622 shares of Colgate-Palmolive worth $650K as of Q3 2026.
Advocate Group sold 700 Colgate-Palmolive shares in Q3 2026, an estimated $63.4K.
Colgate-Palmolive made up 0.1% of Advocate Group's portfolio in Q3 2026, its #91 holding.
Advocate Group first reported a position in Colgate-Palmolive in Q2 2022 and has held it in 18 quarters since.
Advocate Group's Colgate-Palmolive position peaked at $1.94M in Q2 2022.
861 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Advocate Group's 13F filing for Q3 2026, filed 19 Oct 2026.